BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/24/2026 10:16:21 AM | Browse: 1 | Download: 0
 |
Received |
|
2026-02-26 03:22 |
|
Peer-Review Started |
|
2026-02-26 03:22 |
|
First Decision by Editorial Office Director |
|
2026-04-03 07:29 |
|
Return for Revision |
|
2026-04-03 07:29 |
|
Revised |
|
2026-05-09 12:04 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-06-05 03:11 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-06-05 08:25 |
|
Articles in Press |
|
2026-06-05 08:25 |
|
Edit the Manuscript by Language Editor |
|
2026-06-14 22:58 |
|
Typeset the Manuscript |
|
2026-07-21 00:54 |
|
Publish the Manuscript Online |
|
2026-07-24 10:16 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Nanoscience & Nanotechnology |
| Manuscript Type |
Review |
| Article Title |
Mesenchymal stem cell-derived extracellular vesicles as next generation drug delivery platforms
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Sara Akhtar Khan, Saurabh Kumar Jha, Prachi Tiwari, Jagriti Narang, Vinamre Gupta, Sachin Kumar Singh, Kushi Anand, Ramya Lakshmi Rajendran, Prakash Gangadaran and Suhel Parvez |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Basic Science Research Program through the National Research Foundation of Korea |
NRF-2022R1I1A1A01068652 |
|
| Corresponding Author |
Prakash Gangadaran, Department of Nuclear Medicine, School of Medicine, Kyungpook National University, No. 680 Gukchaebosang ro, Jung gu, Daegu 41944, South Korea. prakashg@knu.ac.kr |
| Key Words |
Mesenchymal stem cell-derived extracellular vesicles; Regenerative medicine; Drug delivery; Disease therapy; Translational nanomedicine |
| Core Tip |
Mesenchymal stem cells-derived extracellular vesicles (MSC-EVs) that can be modified to transport therapeutic agents like small drug molecules, RNAs or proteins via various loading techniques. Engineered MSC-EVs facilitate focused delivery to affected tissues such as tumors, cardiovascular damage, neurological issues, inflammatory conditions and wound areas through receptor-mediated absorption and microenvironment-responsive pathways. The inherent biocompatibility, targeting ability and adaptability of MSC-EVs establish them as potential platforms for precision drug delivery and regenerative therapies. |
| Publish Date |
2026-07-24 10:16 |
| Citation |
Khan SA, Jha SK, Tiwari P, Narang J, Gupta V, Singh SK, Anand K, Rajendran RL, Gangadaran P, Parvez S. Mesenchymal stem cell-derived extracellular vesicles as next generation drug delivery platforms. World J Stem Cells 2026; 18(7): 120363
|
| URL |
https://www.wjgnet.com/1948-0210/full/v18/i7/120363.htm |
| DOI |
https://doi.org/10.4252/wjsc.120363 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
